Mylan
-
Teva Pharmaceuticals Announces $40.5 Billion Deal For Allergan’s Generic Drug Unit
International drugmaker Teva Pharmaceuticals has turned its back on its rocky deal with Mylan and hooked up with another business partner. The abrupt about-face today…
-
American Cancer Society Inaugurates CEO’s Against Cancer Chapter
Last Thursday CEOs from the South Eastern Pennsylvania region met at the Philadelphia Union League to inaugurate the PA chapter of the American Cancer Society’s CEOs…














































